Ets. B.I.S

Democratic Republic of Congo Health

BIS manufactures more than 50 pharma products and specialises in injectable and ophthalmic pharmaceuticals for the mass market in DRC and is planning to expand into household cleaning products.

We are invested in Ets. B.I.S through African Rivers Fund, which is managed by XSML. For further information on the fund, the fund manager, and the expected impact of the fund’s investment, click here.

Key facts

Status:
Active
Region

Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.

:
Africa, Central Africa
Countries:
Democratic Republic of Congo
Sector

We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people.

:
Health
Investment type

We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).

:
Intermediated investment
Fund:
African Rivers Fund
Fund Manager:
XSML
Start date

For direct investments, this is the date CDC committed capital to the business or project.

For funds, this is the date that CDC committed capital to the fund.

For underlying fund investments, this is the date that the fund invested capital into the business.e

:
April 2016